A detailed history of Northern Trust Corp transactions in Celcuity Inc. stock. As of the latest transaction made, Northern Trust Corp holds 257,890 shares of CELC stock, worth $3.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
257,890
Previous 200,477 28.64%
Holding current value
$3.3 Million
Previous $3.28 Million 17.12%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$13.98 - $19.15 $802,633 - $1.1 Million
57,413 Added 28.64%
257,890 $3.85 Million
Q2 2024

Aug 14, 2024

BUY
$14.1 - $20.78 $151,137 - $222,740
10,719 Added 5.65%
200,477 $3.28 Million
Q1 2024

May 14, 2024

BUY
$13.74 - $21.6 $90,271 - $141,912
6,570 Added 3.59%
189,758 $4.1 Million
Q4 2023

Feb 13, 2024

BUY
$8.7 - $15.02 $17,704 - $30,565
2,035 Added 1.12%
183,188 $2.67 Million
Q3 2023

Nov 13, 2023

SELL
$8.96 - $10.75 $12,284 - $14,738
-1,371 Reduced 0.75%
181,153 $1.66 Million
Q2 2023

Aug 11, 2023

BUY
$9.39 - $12.18 $1.32 Million - $1.71 Million
140,480 Added 334.13%
182,524 $2 Million
Q1 2023

May 15, 2023

BUY
$9.4 - $12.82 $26,545 - $36,203
2,824 Added 7.2%
42,044 $430,000
Q4 2022

Feb 13, 2023

SELL
$7.55 - $14.01 $1,457 - $2,703
-193 Reduced 0.49%
39,220 $549,000
Q3 2022

Nov 14, 2022

SELL
$8.0 - $10.64 $12,960 - $17,236
-1,620 Reduced 3.95%
39,413 $395,000
Q2 2022

Aug 12, 2022

SELL
$5.35 - $10.11 $359,306 - $678,987
-67,160 Reduced 62.07%
41,033 $374,000
Q1 2022

May 13, 2022

SELL
$7.93 - $13.33 $36,612 - $61,544
-4,617 Reduced 4.09%
108,193 $1.01 Million
Q4 2021

Feb 08, 2022

BUY
$11.96 - $19.35 $1,973 - $3,192
165 Added 0.15%
112,810 $1.49 Million
Q3 2021

Nov 15, 2021

BUY
$17.35 - $24.87 $173,048 - $248,053
9,974 Added 9.71%
112,645 $2.03 Million
Q2 2021

Aug 13, 2021

BUY
$14.25 - $30.93 $914,237 - $1.98 Million
64,157 Added 166.58%
102,671 $2.46 Million
Q1 2021

May 12, 2021

SELL
$10.43 - $17.8 $111,340 - $190,015
-10,675 Reduced 21.7%
38,514 $552,000
Q4 2020

Feb 11, 2021

SELL
$5.13 - $11.72 $27,265 - $62,291
-5,315 Reduced 9.75%
49,189 $451,000
Q3 2020

Nov 16, 2020

BUY
$5.1 - $7.07 $2,713 - $3,761
532 Added 0.99%
54,504 $317,000
Q2 2020

Aug 14, 2020

SELL
$4.42 - $11.04 $81,093 - $202,550
-18,347 Reduced 25.37%
53,972 $374,000
Q1 2020

May 14, 2020

BUY
$5.79 - $11.78 $42,550 - $86,571
7,349 Added 11.31%
72,319 $469,000
Q4 2019

Feb 14, 2020

BUY
$9.47 - $16.71 $75 - $133
8 Added 0.01%
64,970 $691,000
Q3 2019

Nov 13, 2019

BUY
$15.74 - $23.65 $3,132 - $4,706
199 Added 0.31%
64,962 $1.1 Million
Q2 2019

Aug 13, 2019

BUY
$19.88 - $25.0 $19,045 - $23,950
958 Added 1.5%
64,763 $1.62 Million
Q1 2019

May 13, 2019

BUY
$18.38 - $24.44 $35,234 - $46,851
1,917 Added 3.1%
63,805 $1.4 Million
Q4 2018

Feb 12, 2019

BUY
$20.87 - $29.05 $25,524 - $35,528
1,223 Added 2.02%
61,888 $1.48 Million
Q3 2018

Nov 14, 2018

BUY
$20.96 - $30.77 $62,775 - $92,156
2,995 Added 5.19%
60,665 $1.75 Million
Q2 2018

Aug 14, 2018

BUY
$16.13 - $26.99 $593,164 - $992,530
36,774 Added 175.99%
57,670 $1.43 Million
Q1 2018

May 09, 2018

BUY
$13.55 - $21.3 $59,145 - $92,974
4,365 Added 26.4%
20,896 $344,000
Q4 2017

Feb 14, 2018

BUY
$12.12 - $21.65 $200,355 - $357,896
16,531
16,531 $313,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $191M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.